Загрузка...

Gemfibrozil treatment: a comparison with clofibrate.

Gemfibrozil was found to be an effective hypotriglyceridaemic agent in types IV, IIb and V hyperlipoproteinaemia. When given at a dose level of 800 mg/day its activity was nearly of the same order of magnitude as 1.5 g/day of clofibrate.

Сохранить в:
Библиографические подробности
Главные авторы: Howard, A. N., Ghosh, P.
Формат: Artigo
Язык:Inglês
Опубликовано: 1976
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1864044/
https://ncbi.nlm.nih.gov/pubmed/190609
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!